Effect of bortezomib on the efficiency of hematopoietic stem cell mobilization in patients with multiple myeloma
О. С. Покровская, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Larisa A. Kuzmina(Ministry of Health of the Russian Federation), Т. В. Гапонова(Ministry of Health of the Russian Federation), Ф. M. Ахундова, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Е. М. Грецов, E N Parovichnikova, Е С Урнова, Н Н Калинин, Irina Galtseva(National Research Center for Preventive Medicine)
DOAJ (DOAJ: Directory of Open Access Journals)
July 1, 2012
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59